| |
| |
|
| Insider
Information: |
Hecht Peter M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,594,751 |
|
|
Indirect Shares
|
14,622 |
|
|
| Direct
Value |
$18,077,168 |
|
|
|
Indirect Value
|
$118,160 |
|
|
| Total
Shares |
2,609,373 |
|
|
| Total
Value |
$18,195,328 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
| Percentage
Gain/Loss : |
 -53.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ironwood Pharmaceuticals Inc |
IRWD |
Chief Executive Office... |
2019-03-05 |
2,217,366 |
2019-03-05 |
14,550 |
Premium* |
|
|
Cyclerion Therapeutics, Inc. |
CYCN |
|
2024-01-01 |
377,385 |
2024-01-01 |
72 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYCN |
Cyclerion Therapeutics, I... |
|
– • • |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
377,385 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
|
– • • |
2023-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
362,385 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
|
– • • |
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
347,385 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • • |
2023-05-19 |
4 |
A |
$8.68 |
$1,953,000 |
D/D |
225,000 |
327,385 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2021-06-03 |
4 |
B |
$3.28 |
$2,699,998 |
D/D |
823,170 |
2,047,698 |
0.01 |
% |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2021-05-06 |
4 |
B |
$2.43 |
$733,860 |
D/D |
302,000 |
1,224,528 |
0.01 |
% |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2021-05-05 |
4 |
B |
$2.53 |
$1,006,943 |
D/D |
398,001 |
922,528 |
0.01 |
% |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2021-05-04 |
4 |
B |
$2.29 |
$687,000 |
D/D |
300,000 |
524,527 |
0.01 |
% |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2019-07-10 |
4 |
OE |
$6.04 |
$12,080 |
D/D |
2,000 |
225,192 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
223,192 |
223,192 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,455 |
485 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
Chief Executive Officer |
• • – |
2019-04-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
221,736 |
221,736 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-03-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500,000 |
2,217,366 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-01-25 |
4 |
OE |
$4.89 |
$244,500 |
D/D |
50,000 |
4,717,366 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-01-25 |
4 |
AS |
$12.23 |
$361,409 |
D/D |
(29,551) |
4,696,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-01-24 |
4 |
OE |
$4.89 |
$146,700 |
D/D |
30,000 |
4,726,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-01-24 |
4 |
AS |
$12.70 |
$381,000 |
D/D |
(30,000) |
4,696,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-01-23 |
4 |
AS |
$12.66 |
$379,800 |
D/D |
(30,000) |
4,696,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-01-23 |
4 |
OE |
$4.89 |
$146,700 |
D/D |
30,000 |
4,726,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,696,917 |
4,696,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,696,917) |
0 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2017-12-07 |
4 |
S |
$15.00 |
$861,075 |
D/D |
(57,405) |
4,696,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2017-12-07 |
4 |
OE |
$3.76 |
$215,843 |
D/D |
57,405 |
4,754,322 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2017-12-06 |
4 |
OE |
$3.76 |
$310,557 |
D/D |
82,595 |
4,752,917 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2017-12-06 |
4 |
S |
$15.24 |
$853,440 |
D/D |
(56,000) |
4,696,917 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
